Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Assessment of Minimal Residual Disease in a Phase 1b Study of Once-Weekly Carfilzomib Combined with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma

Ola Landgren, MD PhD, Melissa Alsina, MD, Noa Biran, MD, David H. Vesole, MD PhD, Paul K. Wallace, MS, PhD, Belle Fang, Gregory Arnold, Amy Kimball, MD PhD, David S. Siegel, MD PhD

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-133803

Published: 2020

Journal Articles

Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-142622

Published: 2020

Journal Articles

Ofatumumab Plus Hypercvad/MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study

Pallawi Torka, MD, Nishitha Reddy, MD, Adrienne Groman, MS, Angela Kader, Jenna Nichols, Alan Hutson, Cory Mavis, MSc, Joseph Dennis Tario, PhD, Paul K. Wallace, MS, PhD, AnneMarie W. Block, PhD, Sheila N. J. Sait, PhD, Bora E Baysal, MD PhD, Vishala T. Neppalli, MD, Suchitra Sundaram, MD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2019) 134 (Supplement_1): 2817.

https://doi.org/10.1182/blood-2019-123488

Published: 2019

Journal Articles

Immune Monitoring of CD34+ Placental Cell Derived Natural Killer Cell Therapy (PNK-007) in Phase I Study of Multiple Myeloma

William Van Der Touw, Lin Kang, PhD, Joseph Dennis Tario, PhD, Bhavani Stout, Vanessa Voskinarian-Berse, Valentina Rousseva, Paul K. Wallace, MS, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD

Blood (2019) 134 (Supplement_1): 4457.

https://doi.org/10.1182/blood-2019-124509

Published: 2019

Journal Articles

Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)

Sarah A. Holstein, MD PhD, Sarah Cooley, MD, Parameswaran Hari, MBBS, MD, Sundar Jagannath, MD, Catherine R Balint, BSc, William Van Der Touw, Michele L. Donato, MD, Philip L. McCarthy, MD, Paul K. Wallace, MS, PhD, Xiaokui Zhang, PhD, Robert Hariri, MD PhD, Mohamad A. Hussein, MDMBBS, Ravi Vij, MBBS

Blood (2019) 134 (Supplement_1): 4451.

https://doi.org/10.1182/blood-2019-128467

Published: 2019

Journal Articles

Cyclosporine May Inhibit the Effect of Extra-Physiologic Oxygen Shock/Stress on Peripheral Blood Stem Cells

Amro Elshoury, MBBChir, Hans Minderman, PhD, Alexis Conway, PhD, Paul K. Wallace, MS, PhD, Charlie Mantel, Joseph Dennis Tario, PhD, Yeong Choi, Kieran O'Loughin, MS, Carlos Cedeno, PhD, Jenna Nichols, Kahteong Soh, MS, Philip L. McCarthy, MD, George Chen, MD

Blood (2018) 132 (Supplement 1): 3346.

https://doi.org/10.1182/blood-2018-99-119329

Published: 2018

Journal Articles

Increased Monocytic Myeloid-Derived Suppressor Cells in the Marrow of Relapsed/Refractory Acute Myeloid Leukemia Patients Following Induction Chemotherapy

Amanda Przespolewski, DO, Paul K. Wallace, MS, PhD, Tara Cronin, BA, Eunice S. Wang, MD

Blood (2018) 132 (Supplement 1): 5270.

https://doi.org/10.1182/blood-2018-99-120082

Published: 2018

Journal Articles

Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

George Chen, MD, Yali Zhang, MS, Joseph Dennis Tario, PhD, Amanda Herko Przespolewski, MD, Dalin Pan, Patrick Mellors, MD, Christine Ho, MD, Sophia R. Balderman, MD, Maureen Ross, MD PhD, Liselotte Brix, PhD, Paul K. Wallace, MS,PhD, Philip L. McCarthy, MD, Theresa Hahn, PhD

Blood (2017) 130 (Supplement 1): 4496.

https://doi.org/10.1182/blood.V130.Suppl_1.4496.4496

Published: 2017

Journal Articles

Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation

Christine M. Ho, MD, Theresa Hahn, PhD, Paul K. Wallace, MS, PhD, Yali Zhang, Ahmad Fora, MD, George L. Chen, MD, Sarah A. Holstein, MD PhD, Patrick Mellors, Benjamin McCarthy, Sophia R. Balderman, MD, Philip L. McCarthy, MD

Blood (2016) 128 (22): 3454.

https://doi.org/10.1182/blood.V128.22.3454.3454

Published: 2016

Journal Articles

Evolution of Multiparametric Flow Cytometry Testing for Minimal Residual Disease Assessment in Multiple Myeloma and Its Impact on Clinical Outcomes: A Single Institution Experience

Nischala Ammannagari, Paul K. Wallace, MS, PhD, Theresa Hahn, PhD, Yali Zhang, Christine M. Ho, MD, Philip L. McCarthy, MD, Sarah A. Holstein, MD PhD

Blood (2016) 128 (22): 2274.

https://doi.org/10.1182/blood.V128.22.2274.2274

Published: 2016

Journal Articles

Fc Gamma Rll (CD32b) Expression Affects Anti-CD20 Monoclonal Antibody Cellular Responses and Is Down Regulated in Rituximab Resistant Pre-Clinical Models

Cory Mavis, MSc, Kayle Stewart, Juan J Gu, PhD, Paul K. Wallace, MS, PhD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2015) 126 (23): 5127.

https://doi.org/10.1182/blood.V126.23.5127.5127

Published: 2015

Journal Articles

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Pallawi Torka, MD, Paul K. Wallace, MS, PhD, Yali Zhang, George L. Chen, MD, Sophia R. Balderman, MD, Bruno Paiva, PhD, Christine M. Ho, MD, Maureen Ross, MD, Francisco J. Hernandez-Ilizaliturri, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD

Blood (2015) 126 (23): 3173.

https://doi.org/10.1182/blood.V126.23.3173.3173

Published: 2015

Journal Articles

Therapeutic Sensitivity of CD20- Waldenströms Macroglobulinemia Cells Is Determined By Underlying Genomic and Epigenetic Events

Aneel Paulus, MDMS, Sharoon Akhtar, MPhil, Hyejin Yoon, Xue Wang, PhD, Maja Blake-Kuranz, Paul K. Wallace, MS, PhD, Sikander Ailawadhi, MD, Stephen M. Ansell, MD PhD, Anne J. Novak, PhD, Morie A Gertz, MD, Robert A Kyle, MD, Peter Martin, MD, Morton Coleman, MD, Jungsu Kim, PhD, Asher Chanan-Khan, MD, Kasyapa S. Chitta, PhD

Blood (2014) 124 (21): 3115.

https://doi.org/10.1182/blood.V124.21.3115.3115

Published: 2014

Journal Articles

Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival

Theresa Hahn, PhD, Yali Zhang, MPH, Bruno Paiva, George L. Chen, MD, Paul K. Wallace, MS, PhD, Philip L. McCarthy, Jr., MD

Blood (2013) 122 (21): 3348.

https://doi.org/10.1182/blood.V122.21.3348.3348

Published: 2013

Journal Articles

Waldenströms Macroglobulinemia Cell Lines Display Differential Surface Molecule Expression Reflecting Variability In Disease Biology and Potential Impact Of Therapeutic Stress

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Sharoon Akhtar, Maja Kuranz, Paul K. Wallace, MS, PhD, Sikander Ailawadhi, M.D., Kena Miller, A.R.N.P, Candido E. Rivera, MD, Gerardo Colon-Otero, MD, Vivek Roy, M.D., Stephen M Ansell, M.D.Ph.D., Anne J. Novak, PhD, Peter Martin, MD, Morton Coleman, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 5091.

https://doi.org/10.1182/blood.V122.21.5091.5091

Published: 2013

Journal Articles

Interleukin 12 (IL12) and Interferon Gamma (IFNγ) of Donor Origin Not of Patient Origin May Predict Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Azza M Kamel, Nahla M El-Sharkawy, Eman K Abd El-Fattah, Raafat Abd El-Fattah, Mohammed A Samra, Paul K. Wallace, MS, PhD, Hossam K Mahmoud

Blood (2012) 120 (21): 1956.

https://doi.org/10.1182/blood.V120.21.1956.1956

Published: 2012

Journal Articles

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Jan Storek, MD, PhD, Rob Woolson, MS, Paul K. Wallace, MS, PhD, Gregory Sempowski, MD, Peter A. McSweeney, MD, Maureen Mayes, MD, Leslie Crofford, MD, Sharon LeClercq, MD, Richard A. Nash, MD, Keith M. Sullivan, MD

Blood (2011) 118 (21): 4917.

https://doi.org/10.1182/blood.V118.21.4917.4917

Published: 2011

Journal Articles

Signal Transducer and Activator of Transcription 3 Promotes Leukemogenesis

Sampa Ghoshal, Michael T Brady, PhD, Omar Ustwani, MD, Erin Tracy, Jason Den Haese, Paul K. Wallace, MS, PhD, Heinz Baumann, Meir Wetzler, MD

Blood (2011) 118 (21): 1395.

https://doi.org/10.1182/blood.V118.21.1395.1395

Published: 2011

Journal Articles

CD19 Expression in t(8;21)-Negative Acute Myeloid Leukemia Is Not Restricted to Cytogenetically Aberrant Populations.

Jawad Francis, MD, Avinash Dharmadhikari, Sheila N.J. Sait, PhD, George Deeb, MD, Paul K. Wallace, MS, PhD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 4128.

https://doi.org/10.1182/blood.V114.22.4128.4128

Published: 2009

Journal Articles

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Cecilia Y. Arana Yi, MD, Wei Tan, Ph.D., Gregory Wilding, Ph.D., Laurie Ann Ford, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, George Deeb, MD, Paul K. Wallace, MS, PhD, Petr Starostik, MD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 4129.

https://doi.org/10.1182/blood.V114.22.4129.4129

Published: 2009

NARROW

Assessment of Minimal Residual Disease in a Phase 1b Study of Once-Weekly Carfilzomib Combined with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma

Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma

Ofatumumab Plus Hypercvad/MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study

Immune Monitoring of CD34+ Placental Cell Derived Natural Killer Cell Therapy (PNK-007) in Phase I Study of Multiple Myeloma

Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)

Cyclosporine May Inhibit the Effect of Extra-Physiologic Oxygen Shock/Stress on Peripheral Blood Stem Cells

Increased Monocytic Myeloid-Derived Suppressor Cells in the Marrow of Relapsed/Refractory Acute Myeloid Leukemia Patients Following Induction Chemotherapy

Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation

Evolution of Multiparametric Flow Cytometry Testing for Minimal Residual Disease Assessment in Multiple Myeloma and Its Impact on Clinical Outcomes: A Single Institution Experience

Fc Gamma Rll (CD32b) Expression Affects Anti-CD20 Monoclonal Antibody Cellular Responses and Is Down Regulated in Rituximab Resistant Pre-Clinical Models

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Therapeutic Sensitivity of CD20- Waldenströms Macroglobulinemia Cells Is Determined By Underlying Genomic and Epigenetic Events

Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival

Waldenströms Macroglobulinemia Cell Lines Display Differential Surface Molecule Expression Reflecting Variability In Disease Biology and Potential Impact Of Therapeutic Stress

Interleukin 12 (IL12) and Interferon Gamma (IFNγ) of Donor Origin Not of Patient Origin May Predict Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Signal Transducer and Activator of Transcription 3 Promotes Leukemogenesis

CD19 Expression in t(8;21)-Negative Acute Myeloid Leukemia Is Not Restricted to Cytogenetically Aberrant Populations.

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only